<p>MB231 or MCF10A cells were treated with the indicated concentrations of IBTP (black diamonds) or BTPP (gray squares) for 24h. The number of cells in each group at the end of the experiment was measured. The values are mean ± SE of duplicates from two independent experiments. (*<i>p</i><0.05 compared to BTPP).</p
MDA-MB-231 and MCF-7 cells were incubated for 1, 6, or 72 hours with ibandronate (1 to 1,000 μmol/l)...
<p>(<b>A</b>) 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenylte-trazolium bromide (MTT) assays as well as...
<p>Distribution of MDA-MB-231 (A) and D3H2LN (B) cells treated with BPs in different cell cycle phas...
<p>MB231 cells were treated with the indicated concentrations of IBTP. At the end of the treatment, ...
<p>(a) Dose- and time-dependent inhibition of cancer, (b) IC<sub>50</sub> of cancer and normal cells...
<p>The expression of CRITPO, FGF, PKA, EDNRA, LMO1, VEGF-D, LEF-1, PDGFR, PDGFRA, ADCV, and TCF (LEF...
<p>Both HEK-293T and HT-29 cells were cultured to 80% confluency and treated with BBP at a series of...
<p>Splenic B cells (2×10<sup>6</sup>cells/well) were plated with RPMI 1640 supplemented with 10% FBS...
<p>(<b>A</b>) After 48 h of steroid deprivation, MCF-7 cells were cultured in medium containing 2.5%...
<p>Breast cancer cells were exposed to 10 or 20 µm BBP for 24 h. The viability of R2d (A) and MCF-7 ...
Bisphenol A (BPA) is an environmental estrogen that exhibits non-genotoxic carcinogenicity, causing ...
<p>Proliferation was determined by an MTT assay (mean ± SD, n = 4) for genistein (GEN, square), fing...
<p>MB231 cells were treated with 10μM IBTP or EtOH vehicle for 4h, and cell fractions were obtained ...
<p>(A) Basal cell proliferation of human breast cell lines was analyzed using the BrdU incorporation...
<p>(A) Ovarian cancer cells A2780 and OV2008, and normal ovarian cells IOSE80 were treated with PMBP...
MDA-MB-231 and MCF-7 cells were incubated for 1, 6, or 72 hours with ibandronate (1 to 1,000 μmol/l)...
<p>(<b>A</b>) 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenylte-trazolium bromide (MTT) assays as well as...
<p>Distribution of MDA-MB-231 (A) and D3H2LN (B) cells treated with BPs in different cell cycle phas...
<p>MB231 cells were treated with the indicated concentrations of IBTP. At the end of the treatment, ...
<p>(a) Dose- and time-dependent inhibition of cancer, (b) IC<sub>50</sub> of cancer and normal cells...
<p>The expression of CRITPO, FGF, PKA, EDNRA, LMO1, VEGF-D, LEF-1, PDGFR, PDGFRA, ADCV, and TCF (LEF...
<p>Both HEK-293T and HT-29 cells were cultured to 80% confluency and treated with BBP at a series of...
<p>Splenic B cells (2×10<sup>6</sup>cells/well) were plated with RPMI 1640 supplemented with 10% FBS...
<p>(<b>A</b>) After 48 h of steroid deprivation, MCF-7 cells were cultured in medium containing 2.5%...
<p>Breast cancer cells were exposed to 10 or 20 µm BBP for 24 h. The viability of R2d (A) and MCF-7 ...
Bisphenol A (BPA) is an environmental estrogen that exhibits non-genotoxic carcinogenicity, causing ...
<p>Proliferation was determined by an MTT assay (mean ± SD, n = 4) for genistein (GEN, square), fing...
<p>MB231 cells were treated with 10μM IBTP or EtOH vehicle for 4h, and cell fractions were obtained ...
<p>(A) Basal cell proliferation of human breast cell lines was analyzed using the BrdU incorporation...
<p>(A) Ovarian cancer cells A2780 and OV2008, and normal ovarian cells IOSE80 were treated with PMBP...
MDA-MB-231 and MCF-7 cells were incubated for 1, 6, or 72 hours with ibandronate (1 to 1,000 μmol/l)...
<p>(<b>A</b>) 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenylte-trazolium bromide (MTT) assays as well as...
<p>Distribution of MDA-MB-231 (A) and D3H2LN (B) cells treated with BPs in different cell cycle phas...